New Section 232 tariffs impose up to 100% duties on patented drugs while offering relief tied to onshoring and MFN pricing commitments.
| less than a minute read
From Zero to 100% – New Section 232 Tariffs on Patented Drugs and the High-Stakes Onshoring and MFN Choices Ahead

/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-05-22-14-15-25-334-6a1064fd1a1fd2238dcdffd6.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-05-22-14-13-14-735-6a10647a1a1fd2238dcdfd49.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-05-22-14-12-01-163-6a1064311a1fd2238dcdfbfd.jpg)
/Passle/6880addbd954bf894713d5af/SearchServiceImages/2026-05-22-14-09-56-202-6a1063b41a1fd2238dcdf984.jpg)